• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OSCOR INC. ABIOMED INTRODUCER KIT FOR IMPELLA®; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OSCOR INC. ABIOMED INTRODUCER KIT FOR IMPELLA®; INTRODUCER, CATHETER Back to Search Results
Model Number 0052-3006
Device Problem Fluid/Blood Leak (1250)
Patient Problems Cardiogenic Shock (2262); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/16/2021
Event Type  malfunction  
Manufacturer Narrative
Conclusion not yet available, evaluation in process.A follow-up will be submitted as soon as the investigation is complete.
 
Event Description
Patient is suffering from post cardiotomy cardiogenic shock.It was reported there was a 23f introducer that was leaking between the sheath and graft.Sheath was flushed and prepped with dilator inserted into 10/30 vascutek graft and 2 graft locks attached.Leaking noted out of graft.There was a five minute delay in procedure to find replacement sheath and exchange into graft.Blood loss was reported, amount of blood loss is unknown.Procedure was completed with another sheath.No adverse patient effects reported.
 
Manufacturer Narrative
The device was used in treatment.One 23f abiomed axillary sheath was returned.Traces of blood was found inside and outside of the sheath.The returned sheath was observed using a vertex at higher magnification and no cracks, holes or gaps were found.The sheath score lines were observed to be prominent on the outer surface.The sheath was leak tested per iso 11070 standard and procedure for leak test.Sheath leak test results did not show any leakage through the sheath score lines or the valve.Further investigation revealed that wall thickness of the scoreline has been reduce to improve the peel strength.Reduced wall thickness of the scoreline could have made the sheath susceptible to collapsing when used with graft locks, and that could have caused leakage.However, all devices that have been evaluated have met the current dimensional, visual, and functional requirements in the 23f sheath product specification.Further investigation revealed that wall thickness of the scoreline has been reduce to improve the peel strength.Reduced wall thickness of the scoreline could have made the sheath susceptible to collapsing when used with graft locks, and that could have caused leakage.However, all devices that have been evaluated have met the current dimensional, visual, and functional requirements in the 23f sheath product specification.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.Per operations procedure(s) adelante, adelante-s and adelante-s2 sheath extrusion appropriate extrusion tool is selected for the part to be extruded and is inspected prior to the extrusion run.Peel strength and critical dimensions are verified on every 100th extruded sheath as per procedure.Per abiomed introducer sheath in-process and final sample size: 100% inspection the sheath is inspected with a naked eye at a distance of 12" to 18" to ensure the sheath is free of kinks, cracks, splits, sinks and any other damages.Leak test is performed as per procedure.Abiomed instructions for use (ifu) is provided with the product.Based on the investigation, a capa was not required.There was no new failure mode identified and the risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report isbased upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABIOMED INTRODUCER KIT FOR IMPELLA®
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
OSCOR INC.
3816 desoto blvd.
palm harbor FL 34683
Manufacturer (Section G)
OSCOR INC.
3816 desoto blvd.
palm harbor FL 34683
Manufacturer Contact
doug myers
3816 desoto blvd.
palm harbor, FL 34683
7279372511
MDR Report Key12167863
MDR Text Key264488676
Report Number1035166-2021-00067
Device Sequence Number1
Product Code DYB
UDI-Device Identifier00885672009755
UDI-Public00885672009755
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K122084
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/01/2024
Device Model Number0052-3006
Device Catalogue Number0052-3006
Device Lot NumberPQOC11882
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/06/2021
Date Manufacturer Received12/10/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age67 YR
Patient SexMale
Patient RaceWhite
-
-